These findings suggest the importance of patients' VEGF levels during HPS, support the involvement of VEGF responses in HPS pathogenesis, and suggest targeting VEGF responses as a potential therapeutic approach. The gene discussed is VEGFA; the disease is Hermansky-Pudlak syndrome.